Voyager Therapeutics (VYGR) Return on Sales (2015 - 2026)
Voyager Therapeutics (VYGR) posted Return on Sales of 0.11% for Q1 2026, down 503.95% sequentially from 0.02% in Q4 2025, and down 6.0% YoY from 0.11% in Q1 2025.
Voyager Therapeutics (VYGR) Return on Sales (2015 - 2026) Analysis & Trends
Voyager Therapeutics has reported Return on Sales for 12 years, with the latest figure at 0.11% in Q1 2026.
- Quarterly Return on Sales fell 6.0% year-over-year to 0.11% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.03% (down 2.0% YoY) and the FY2025 annual result came in at 0.03%, down 2.0% from the prior year.
- Return on Sales eased to 0.11% in Q1 2026 per VYGR's latest filing, from 0.02% in the prior quarter.
- Over five years, Return on Sales peaked at 0.15% in Q4 2022 and troughed at 0.32% in Q1 2022.
- A 5-year average of 0.05% and a median of 0.02% in 2025 frame the typical range for Return on Sales.
- The widest YoY moves for Return on Sales: up 57 bps in 2022, down 19 bps in 2022.
- Over 5 years, Return on Sales stood at 0.15% in 2022, then slumped by 96 bps to 0.01% in 2023, then tumbled by 943 bps to 0.05% in 2024, then surged by 67 bps to 0.02% in 2025, then sank by 504 bps to 0.11% in 2026.
- According to Business Quant data, Return on Sales over the past three periods registered 0.11%, 0.02%, and 0.02% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.99 Bn | 132.14 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.80 Bn | 78.80 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.38 Bn | 60.19 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 60.70 Bn | 55.56 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.45 Bn | 10.06 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.21 Bn | 26.37 Bn | - | 0.00% |
| 10 | Voyager Therapeutics | 202.53 Mn | 86.19 Mn | - | -0.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.08% |
| Mar 31, 2026 | -0.11% |
| Dec 31, 2025 | -0.02% |
| Sep 30, 2025 | -0.02% |
| Jun 30, 2025 | -0.06% |
| Mar 31, 2025 | -0.05% |
| Dec 31, 2024 | -0.05% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | 0.01% |
| Sep 30, 2023 | -0.06% |
| Jun 30, 2023 | -0.05% |
| Mar 31, 2023 | 0.01% |
| Dec 31, 2022 | 0.15% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | -0.27% |
| Mar 31, 2022 | -0.32% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | -0.57% |